Jan 21, 2024, 05:16
Yüksel Ürün: ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients
Yüksel Ürün, Professor of Medical Oncology at AnkaraUniversity, shared the photo of Pashtoon Kasi on X, with the following text:
“ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients.
Promising results from BESPOKE CRC and AGITG DYNAMIC-Rectal trials.
A step forward in personalized cancer care!”
Source: Yüksel Ürün / X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29